Tag archive

PromarkerD

30 million diabetics in US deserve to know their future kidney disease status

in Pharmaceutical News
Proteomics International and PromarkerD at BIO 2019 saying 30 million diabetics in US deserve to know their future kidney disease status

Proteomics International (PILL; ASX: PIQ) will be at the 2019 BIO International Convention in Philadelphia (stand #2349) preparing for the US roll-out of PromarkerD, a blood test that can diagnose and predict whether a healthy patient will develop diabetic kidney disease. “PromarkerD is world-beating technology and needs to get into the hands of specialists and physicians to stem the tsunami of kidney disease which is causing over 40,000 deaths per year in the US, with related healthcare spending exceeding US$100…

Keep Reading

Go to Top